Kamb, Alexander
A2 Biotherapeutics, Inc.,
United States
2025 Rank: 40600
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Developmental Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1387 out of 157999 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 40600 | 44735 |
| Total Cites | 14032 | 14814 |
| H-index | 34 | 36 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 741 | 750 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 4689 | 4837 |
| Number of Single+First+Last Authored Papers | 77 | 77 |
| Total Cites to Single+First+Last Authored Papers | 6153 | 6452 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11331 | 11718 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.26 |
| Self-Citation Percentage |
5.28%
|
|
Kamb, Alexander
A2 Biotherapeutics;,
United States
2024 Rank: 37657
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Developmental Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1332 out of 149337 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 37657 | 42737 |
| Total Cites | 13719 | 14467 |
| H-index | 34 | 35 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 725 | 734 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 4620 | 4767 |
| Number of Single+First+Last Authored Papers | 75 | 75 |
| Total Cites to Single+First+Last Authored Papers | 6000 | 6279 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11055 | 11431 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.27 |
| Self-Citation Percentage |
5.17%
|
|
Kamb, Alexander
A2 Biotherapeutics,
United States
2023 Rank: 35263
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Developmental Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1266 out of 138178 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 35263 | 40135 |
| Total Cites | 13407 | 14146 |
| H-index | 34 | 35 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 705 | 714 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 4541 | 4684 |
| Number of Single+First+Last Authored Papers | 74 | 74 |
| Total Cites to Single+First+Last Authored Papers | 5766 | 6042 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10768 | 11143 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.27 |
| Self-Citation Percentage |
5.22%
|
|
Kamb, Alexander
A2 Biotherapeutics,
United States
2022 Rank: 32498
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Developmental Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1211 out of 127685 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 32498 | 37296 |
| Total Cites | 13058 | 13758 |
| H-index | 33 | 34 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 670 | 679 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 4444 | 4584 |
| Number of Single+First+Last Authored Papers | 71 | 71 |
| Total Cites to Single+First+Last Authored Papers | 5639 | 5888 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10443 | 10804 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.27 |
| Self-Citation Percentage |
5.09%
|
|
Kamb, Alexander
A2 Biotherapeutics Inc.,
United States
2021 Rank: 31618
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Developmental Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1256 out of 123644 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 31618 | 36175 |
| Total Cites | 12764 | 13410 |
| H-index | 32 | 33 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 652 | 659 |
| Number of Single+First Authored Papers | 35 | 35 |
| Total Cites to Single+First Authored Papers | 4359 | 4489 |
| Number of Single+First+Last Authored Papers | 68 | 68 |
| Total Cites to Single+First+Last Authored Papers | 5531 | 5753 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10199 | 10543 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.27 |
| Self-Citation Percentage |
4.82%
|
|
Kamb, Alexander
Amgen Incorporated,
United States
2020 Rank: 28285
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Developmental Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1230 out of 105600 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 28285 | 32477 |
| Total Cites | 12358 | 12998 |
| H-index | 32 | 33 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 619 | 625 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 4250 | 4382 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 5405 | 5624 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9834 | 10174 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.28 |
| Self-Citation Percentage |
4.92%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.